Steroids for severe Pneumocystis pneumonia in ICU patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether giving steroids (anti-inflammatory medicines) to people with a severe lung infection called Pneumocystis pneumonia (PJP) can improve outcomes. It is for patients who are in the ICU and do not have HIV, which is a different group than typical PJP patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be in the intensive care unit (ICU) because of severe pneumonia.
- You must have a positive test (PCR or next-gen sequencing) for Pneumocystis pneumonia (PJP) from your breathing samples.
- You must not have HIV.
- You must not have already been treated with steroids for this pneumonia before coming to the ICU.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different lengths of steroid treatment for people with severe Pneumocystis pneumonia (a serious lung infection). If you have improved enough by day 10 to breathe without oxygen, the study will see if stopping steroids sooner is as safe and effective as continuing them.
This trial tests whether adding anti-inflammatory medicine (steroids) to usual care helps people with severe pneumonia recover faster. It only includes patients who are seriously ill in the ICU, and the goal is to find the best way to reduce lung inflammation and improve outcomes.
This trial tests whether giving corticosteroids (anti-inflammatory medicines) to adults with severe psittacosis pneumonia in the ICU can help them recover better. It aims to see if this treatment reduces the need for breathing support or improves survival.
This trial tests whether steroids (corticosteroids) can help adults with severe pneumonia caused by adenovirus (a common virus) who are in the ICU. The goal is to see if steroids reduce inflammation and improve recovery.
This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.
This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.
Hear when a new Pneumocystis Jiroveci Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.